Next Generation Cancer Vaccines—Make It Personal!

por Terbuch, Angelika, Lopez, Juanita
Publicado 2018

Combining DNA damaging therapeutics with immunotherapy: more haste, less speed

por Brown, Jessica S, Sundar, Raghav, Lopez, Juanita
Publicado 2018

Development of Molecularly Targeted Agents and Immunotherapies in Glioblastoma: A Personalized Approach

por Coleman, Niamh, Ameratunga, Malaka, Lopez, Juanita
Publicado 2018

Dancing with the DNA damage response: next-generation anti-cancer therapeutic strategies

por Minchom, Anna, Aversa, Caterina, Lopez, Juanita
Publicado 2018

Precision Medicine for Molecularly Targeted Agents and Immunotherapies in Early-Phase Clinical Trials

por Lopez, Juanita, Harris, Sam, Roda, Desam, Yap, Timothy A
Publicado 2015

Immuno-oncology combinations: raising the tail of the survival curve

por Harris, Samuel J., Brown, Jessica, Lopez, Juanita, Yap, Timothy A.
Publicado 2016

CNS cancer immunity cycle and strategies to target this for glioblastoma

por Ameratunga, Malaka, Coleman, Niamh, Welsh, Liam, Saran, Frank, Lopez, Juanita
Publicado 2018

‘You give me fever!’: are health services ready for immune cell engager therapy in advanced solid malignancies?

por Pettinger, Claire, Livings, Claire, Grochot, Rafael, Furness, Andrew, Lopez, Juanita
Publicado 2022

A risk-based approach to experimental early phase clinical trials during the COVID-19 pandemic

por Tiu, Crescens, Shinde, Rajiv, Yap, Christina, Rao Baikady, Bindumalini, Banerji, Udai, Minchom, Anna R, de Bono, Johann S, Lopez, Juanita S
Publicado 2020

Radium-223 in combination with paclitaxel in cancer patients with bone metastases: safety results from an open-label, multicenter phase Ib study

por Geva, Ravit, Lopez, Juanita, Danson, Sarah, Joensuu, Heikki, Peer, Avivit, Harris, Samuel J., Souza, Fabricio, Pereira, Kaline M. C., Perets, Ruth
Publicado 2018

Target-based therapeutic matching of phase I trials in patients with metastatic breast cancer in a tertiary referral centre

por O’Carrigan, Brent, Lim, Joline Si Jing, Jalil, Awais, Harris, Samuel John, Papadatos-Pastos, Dionysis, Banerji, Udai, Lopez, Juanita, de Bono, Johann Sebastian, Yap, Timothy Anthony
Publicado 2018

A study of 1088 consecutive cases of electrolyte abnormalities in oncology phase I trials

por Ingles Garces, Alvaro H., Ang, Joo Ern, Ameratunga, Malaka, Chénard-Poirier, Maxime, Dolling, David, Diamantis, Nikolaos, Seeramreddi, Satyanarayana, Sundar, Raghav, de Bono, Johann, Lopez, Juanita, Banerji, Udai
Publicado 2018

Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors

por Joerger, Markus, Calvo, Emiliano, Laubli, Heinz, Lopez, Juanita, Alonso, Guzmán, Corral de la Fuente, Elena, Hess, Dagmar, König, David, Sanchez Perez, Vicky, Bucher, Christoph, Jethwa, Sangeeta, Garralda, Elena
Publicado 2023

Study protocol for a randomised controlled trial of enhanced informed consent compared to standard informed consent to improve patient understanding of early phase oncology clinica...

por Pal, Abhijit, Stapleton, Sarah, Yap, Christina, Lai-Kwon, Julia, Daly, Robert, Magkos, Dimitrios, Baikady, Bindumalini Rao, Minchom, Anna, Banerji, Udai, De Bono, Johann, Karikios, Deme, Boyle, Frances, Lopez, Juanita
Publicado 2021

PARP inhibition utilized in combination therapy with Olaparib‐Temozolomide to achieve disease stabilization in a rare case of BRCA1‐mutant, metastatic myxopapillary ependymoma

por Mahalingam, Preethika, Smith, Sam, Lopez, Juanita, Sharma, Rajaei K, Millard, Thomas, Thway, Khin, Fisher, Cyril, Reardon, David A, Jones, Robin, Nicholson, Andrew G, Cunningham, David, Welsh, Liam, Sharma, Bhupinder
Publicado 2023

A first-in-human phase 1 and pharmacological study of TAS-119, a novel selective Aurora A kinase inhibitor in patients with advanced solid tumours

por Robbrecht, Debbie G. J., Lopez, Juanita, Calvo, Emiliano, He, Xiaomin, Hiroshi, Hirai, Soni, Nital, Cook, Natalie, Dowlati, Afshin, Fasolo, Angelica, Moreno, Victor, Eskens, Ferry A. L. M., de Bono, Johann S.
Publicado 2020

Phase 1 dose-finding and pharmacokinetic study of eribulin-liposomal formulation in patients with solid tumours

por Evans, T. R. Jeffry, Dean, Emma, Molife, L. Rhoda, Lopez, Juanita, Ranson, Malcolm, El-Khouly, Fatima, Zubairi, Ishtiaq, Savulsky, Claudio, Reyderman, Larisa, Jia, Yan, Sweeting, Lorna, Greystoke, Alastair, Barriuso, Jorge, Kristeleit, Rebecca
Publicado 2019

Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease

por Collins, Dearbhaile Catherine, Sundar, Raghav, Constantidinou, Anastasia, Dolling, David, Yap, Timothy Anthony, Popat, Sanjay, O’Brien, Mary E., Banerji, Udai, de Bono, Johann Sebastian, Lopez, Juanita Suzanne, Tunariu, Nina, Minchom, Anna
Publicado 2020

Correction to: Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease

por Collins, Dearbhaile Catherine, Sundar, Raghav, Constantinidou, Anastasia, Dolling, David, Yap, Timothy Anthony, Popat, Sanjay, O’Brien, Mary E., Banerji, Udai, de Bono, Johann Sebastian, Lopez, Juanita Suzanne, Tunariu, Nina, Minchom, Anna
Publicado 2021

A Wolf in Sheep's Clothing: Systemic Immune Activation Post Immunotherapy

por Tiu, Crescens, Shinde, Rajiv, Pal, Abhijit, Biondo, Andrea, Lee, Alex, Tunariu, Nina, Jhanji, Shaman, Grover, Vimal, Tatham, Kate, Gruber, Pascale, Banerji, Udai, De Bono, Johann S., Nicholson, Emma, Minchom, Anna R., Lopez, Juanita S.
Publicado 2021